Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Net Cash Flow (2016 - 2025)

Healthstream (HSTM) has disclosed Net Cash Flow for 16 consecutive years, with -$17.4 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow fell 944.65% to -$17.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$23.3 million through Dec 2025, down 221.54% year-over-year, with the annual reading at -$23.3 million for FY2025, 221.54% down from the prior year.
  • Net Cash Flow for Q4 2025 was -$17.4 million at Healthstream, down from $1.5 million in the prior quarter.
  • The five-year high for Net Cash Flow was $18.3 million in Q3 2023, with the low at -$25.2 million in Q2 2025.
  • Average Net Cash Flow over 5 years is -$12300.0, with a median of $1.8 million recorded in 2024.
  • The sharpest move saw Net Cash Flow surged 327.45% in 2024, then crashed 944.65% in 2025.
  • Over 5 years, Net Cash Flow stood at -$8.5 million in 2021, then skyrocketed by 73.06% to -$2.3 million in 2022, then plummeted by 66.97% to -$3.8 million in 2023, then skyrocketed by 153.51% to $2.1 million in 2024, then plummeted by 944.65% to -$17.4 million in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at -$17.4 million, $1.5 million, and -$25.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.